While AI offers the lure of efficiency and cleaner writing in scientific research, maintaining the principles of authorship and intellectual engagement is perhaps more important than ever before.
|Articles|June 5, 1996
Konica lands generic x-ray contrast agent
Konica Corp. has signed an agreement with Fuji Pharmaceuticalfor Japanese sales of Oiparomin, a generic x-ray contrast agent,according to Japan's Comline Business Data. The agent was approvedby the country's Ministry of Health and Welfare in March and
Advertisement
Konica Corp. has signed an agreement with Fuji Pharmaceuticalfor Japanese sales of Oiparomin, a generic x-ray contrast agent,according to Japan's Comline Business Data. The agent was approvedby the country's Ministry of Health and Welfare in March and aproduct launch will occur as soon as final pricing approval isreceived in July, Comline said.
Advertisement
Related to this article
The cloud-based NextMR platform reportedly provides automated 3D bone images of conventional spine MRI images in less than 60 seconds.
Incorporation of pseudocapsule presence into a modified Clear Cell Likelihood Score (m-ccLS) was associated with a greater than 11 percent higher AUC in differentiating benign and malignant renal masses on mpMRI, according to a new study.
For patients with hepatocellular carcinoma (HCC), perfusion beyond tumor margin on contrast-enhanced ultrasound that exceeds gray-scale ultrasound tumor measurement by 5 mm is associated with a 76 percent higher risk of worse recurrence-free survival, according to newly published research.
In the latest episode of his “Interventional Radiology in Focus” series, Mina Makary, MD, discusses the utility of prostatic artery embolization for treating benign prostatic hyperplasia, key imaging considerations and pertinent technique pearls to help facilitate optimal outcomes.
The AI-powered SwiftSight Body Composition software reportedly provides automated quantification of muscle and adipose tissue after a brief MRI scan.
In the second of a three-part podcast episode, Wendie Berg, MD, PhD, FACR, FSBI, Manisha Bahl, MD, and Amy Patel, MD discuss how to handle disagreements with adjunctive AI in breast imaging, whether to include AI assessments in PACS, and whether patients should pay for the use of adjunctive AI.
Has the barrage of passwords, PINs and authenticator apps gone around the bend to a point where it hampers efficiency and productivity?
Advertisement
Advertisement
Trending on Diagnostic Imaging
1
FDA Clears AI-Powered Platform for Converting Spine MRIs to 3D Visualizations
2
Study Shows Impact of Key mpMRI Features for Enhancing Assessment of Renal Masses
3
FDA Clears MRI-Based AI Software for Body Composition Analysis
4
Tumor Margin Marker on Contrast-Enhanced Ultrasound May Predict Worse Outcomes in Patients with HCC
5